Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome

Ali Al Ameri MD Charles Koller MD Hagop Kantarjian MD Farhad Ravandi MD Srdan Verstovsek MD Gautam Borthakur MD Sherry Pierce RN Gloria Mattiuzzi MD

首页> 外文期刊>Cancer >Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome

【24h】

Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome

机译：成人急性髓样白血病或高危骨髓增生异常综合症缓解诱导化疗期间的急性肺衰竭

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AbstractBACKGROUND:Acute pulmonary failure during remission induction therapy is a serious complication in patients with acute myeloid leukemia (AML). To the authors' knowledge, the course and prognosis of such patients is not well known.

机译：摘要背景：缓解诱导治疗期间的急性肺衰竭是急性髓细胞性白血病（AML）患者的严重并发症。据作者所知，此类患者的病程和预后尚不清楚。

著录项

来源
《Cancer》 |2010年第1期|p.93-97|共5页
作者
Ali Al Ameri MD Charles Koller MD Hagop Kantarjian MD Farhad Ravandi MD Srdan Verstovsek MD Gautam Borthakur MD Sherry Pierce RN Gloria Mattiuzzi MD;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
acute pulmonary failure; acute leukemia; adults; prognosis;

机译：急性肺衰竭;急性白血病;成人;预后;

相似文献

外文文献
中文文献
专利

1. Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome. [J] . Al Ameri A, Koller C, Kantarjian Cancer: A Journal of the American Cancer Society . 2010,第1期

机译：成人急性髓样白血病或高危骨髓增生异常综合征的缓解诱导化疗期间的急性肺衰竭。
2. Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy. [J] . Grovdal M, Karimi M, Khan R, British Journal of Haematology . 2010,第3期

机译：氮杂胞苷维持治疗用于高危骨髓增生异常综合症（MDS）或MDS后急性骨髓性白血病的患者，诱导化疗后完全缓解。
3. Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy [J] . Michael Grövdal, Mohsen Karimi, Rasheed Khan, British Journal of Haematology . 2010,第3期

机译：氮杂胞苷维持治疗用于高危骨髓增生异常综合征（MDS）或MDS后急性髓细胞性白血病的患者，诱导化疗后完全缓解
4. Ras gene mutation in acute myeloid leukemia and Myelodysplastic syndromes: a meta-analysis of its occurrence and prognostic relevance [C] . Cheng Jingru, Wang Peng, Zhang Tai, International Conference on Advanced Materials and Computer Science . 2016

机译：RAS基因突变在急性髓性白血病和髓细胞增强综合征中：荟萃分析其发生和预后相关性
5. Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level [D] . Chen, Jiahao. 2018

机译：在干细胞水平上骨髓增生异常综合征进展为急性髓细胞性白血病
6. Low-dose clofarabine in combination with a standard remission induction in patients aged 18–60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial [O] . Dominik Selleslag, Stefan Suciu, Giovanna Meloni, 2017

机译：低剂量氯法拉滨联合标准缓解诱导治疗以前未接受过治疗的中度和重度急性髓性白血病或高危骨髓增生异常综合征的18-60岁患者：EORTC / GIMEMA AML-14A的I / II期综合结果试用
7. Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome [O] . Ali Al Ameri, Charles Koller, Hagop Kantarjian, 2009

机译：缓解诱导型化疗的急性肺部衰竭，急性髓性白血病或高危髓细胞增强症综合征

Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome

摘要

著录项

相似文献

相关主题

期刊订阅